Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
21 hedge funds and large institutions have $48M invested in Entasis Therapeutics Holdings Inc. in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
11% more funds holding
Funds holding: 19 → 21 (+2)
13% less capital invested
Capital invested by funds: $54.9M → $48M (-$6.88M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$122K |
| 2 |
Renaissance Technologies
New York
|
+$119K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.4K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$33K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$16.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$3.27M |
| 2 |
Millennium Management
New York
|
-$183K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$39K |
| 4 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$10K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.53K |
ETTX Hedge Fund Activity: Q3 2019 in Review
21 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q3 2019, worth a combined $48M — down 13% from $54.9M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ETTX positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Raymond James Financial Services Advisors, opening a new position worth an estimated $122K. The largest seller was Eventide Asset Management, cutting an estimated $3.27M.
- 21 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q3 2019, up from 19 in Q2 2019.
- Funds reported $48M of Entasis Therapeutics Holdings Inc. stock for Q3 2019, down 13% quarter-over-quarter.
- 5 funds opened new Entasis Therapeutics Holdings Inc. positions in Q3 2019 and 3 closed out, a net change of +2 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q3 2019 was Raymond James Financial Services Advisors, an estimated $122K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q3 2019 was Eventide Asset Management, an estimated $3.27M sold.
Based on aggregated 13F filings for Q3 2019.